BusinessCRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer TherapiesBy Nasdaq OMXAug 22, 2017, 11:30 AM UTC
BusinessMassachusetts General Hospital Improves Communication in Its Operating Rooms With VoceraBy Nasdaq OMXDec 9, 2015, 1:00 PM UTC
